Family Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-2,064	Closed	-$167K	–	253
2025 Q1	$167K	Hold	2,064	–	–	0.03%	179
2024 Q4	$186K	Sell	2,064 -1,110	-35%	-$108K	0.03%	163
2024 Q3	$314K	Sell	3,174 -3,247	-51%	-$319K	0.05%	135
2024 Q2	$595K	Sell	6,421 -5,824	-48%	-$522K	0.11%	92
2024 Q1	$1.16M	Buy	12,245 +2,592	+27%	+$241K	0.21%	72
2023 Q4	$862K	Buy	9,653 +4,544	+89%	+$337K	0.18%	69
2023 Q3	$373K	Sell	5,109 -825	-14%	-$65.9K	0.09%	92
2023 Q2	$494K	Buy	5,934 +4,784	+416%	+$400K	0.11%	81
2023 Q1	$87.6K	Hold	1,150	–	–	0.02%	133
2022 Q4	$95.5K	Buy	+1,150	New	+$93.1K	0.02%	150
2022 Q1	–	Sell	-7,009	Closed	-$785K	–	189
2021 Q4	$785K	Buy	7,009 +1,514	+28%	+$183K	0.2%	81
2021 Q3	$691K	Buy	+5,495	New	+$708K	0.19%	85
2020 Q4	–	Sell	-1,150	Closed	-$128K	–	181
2020 Q3	$128K	Buy	+1,150	New	+$129K	0.06%	117
2020 Q2	–	Sell	-1,150	Closed	-$89K	–	181
2020 Q1	$89K	Hold	1,150	–	–	0.04%	140
2019 Q4	$109K	Hold	1,150	–	–	0.04%	163
2019 Q3	$88K	Hold	1,150	–	–	0.03%	151
2019 Q2	$101K	Buy	+1,150	New	+$98.1K	0.04%	145